Current Legal Status

Active Legislation

Psilocybin remains a Schedule I controlled substance under Rhode Island law. A therapeutic access bill passed the Rhode Island Senate Health Committee in 2025 and advocates expect a floor vote in 2026.

Key Legislation

S.0128 (2024) proposed a psilocybin therapeutic services act — passed Senate Health Committee. H.5923 (2025) companion bill introduced in the House. Rhode Island's small size and progressive politics make it a strong candidate for early adoption.

Clinical Trials

Brown University has broad research programs. Check ClinicalTrials.gov for Providence-area enrolling psilocybin studies.

Advocacy Organizations

Rhode Island Psychedelic Society, Healing Advocacy Fund.